{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:13:27Z","timestamp":1780539207822,"version":"3.54.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,5]]},"DOI":"10.1007\/bf01738297","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T06:25:47Z","timestamp":1118643947000},"page":"207-209","source":"Crossref","is-referenced-by-count":29,"title":["A long-term clinical trial of interferon alpha-therapy in essential thrombocythemia"],"prefix":"10.1007","volume":"64","author":[{"given":"G.","family":"Middelhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Boll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF01738297_CR1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01728197","volume":"66","author":"B Baumann","year":"1988","unstructured":"Baumann B, Hillmar I, Hehlmann R (1988) Untersuchungen zur Thrombozytenfunktion bei essentieller Thrombozyth\u00e4mie und reaktiver Thrombozytose. Klin Wochenschr 66: 199\u2013207","journal-title":"Klin Wochenschr"},{"key":"BF01738297_CR2","first-page":"9","volume":"8","author":"HK Breddin","year":"1985","unstructured":"Breddin HK (1985) Thrombozyt\u00e4re St\u00f6rungen. Berichte \u00d6sterreich Ges Klin Chemie 8: 9\u201312","journal-title":"Berichte \u00d6sterreich Ges Klin Chemie"},{"key":"BF01738297_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(88)90005-0","volume":"II","author":"FJ Giles","year":"1988","unstructured":"Giles FJ, Gray AG, Brozovic M, Grant IR, Machin SJ, Richards JDM, Venutas S, Singer CRJ, Yong KL, Davies SC, Hoffbrand AV, Mehta AB, Thomas MJG, Goldstone AH (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet II: 70\u201372","journal-title":"Lancet"},{"key":"BF01738297_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0140-6736(89)92142-9","volume":"I","author":"H Gisslinger","year":"1989","unstructured":"Gisslinger H, Linkesch W, Fritz E, Ludwig H, Chott A, Radaszkiewicz T (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet I: 634\u2013637","journal-title":"Lancet"},{"key":"BF01738297_CR5","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00199157","volume":"25","author":"H Ludwig","year":"1987","unstructured":"Ludwig H, Linkesch W, Gisslinger H, Fritz E, Radaszkiewicz T, Chott A. Mickscher M, Flener R (1987) Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunol Immunother 25: 266\u2013273","journal-title":"Cancer Immunol Immunother"},{"key":"BF01738297_CR6","first-page":"244","volume":"3","author":"D May","year":"1989","unstructured":"May D, Wandl UB, Niederle N (1989) Behandlung der essentiellen Thrombozyth\u00e4mie mit Interferon-alpha-2 b. Lancet 3: 244","journal-title":"Lancet"},{"key":"BF01738297_CR7","first-page":"177","volume":"3","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 3: 177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01738297_CR8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2141.1991.tb04418.x","volume":"78","author":"P Wussow von","year":"1991","unstructured":"Wussow P von, Jakschies D, Freund M, Hehlmann R, Brockhaus F, Hochkeppel H, Horisberger M, Deicher H (1991) Treatment of antirecombinant interferon-alpha 2 antibody-positive CML patients with natural interferon-alpha. Br J Haematol 78: 210\u2013216","journal-title":"Br J Haematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01738297\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01738297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T10:27:10Z","timestamp":1557311230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01738297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1992,5]]}},"alternative-id":["BF01738297"],"URL":"https:\/\/doi.org\/10.1007\/bf01738297","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,5]]}}}